Notes in 03_Endometrial Cancer

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/10/2024	Presentation of {{c2::Endometrial Cancer}}  {{c1::Abnormal vaginal bleeding}} {{c1::Post menopausal bleeding}}
Published	02/10/2024	Histology of Endometrial Cancer is {{c1::Adenocarcinoma (80%)}}
Published	02/10/2024	Hormone Associated with Endometrial Cancer is {{c1::Oestrogen}}
Published	02/10/2024	Risk Factors of Endometrial Cancer  {{c1::Obesity}}, {{c1::Diabetes}}, {{c1::Unopposed E2 therapy}}{{c1::Endometrial atypical hyperplasia}}
Published	02/10/2024	Precancerous Condition Associated with Endometrial Cancer is {{c1::Atypical endometrial hyperplasia}}
Published	02/10/2024	{{c1::2-week}}-wait urgent cancer referral for {{c2::Endometrial}} cancer in the case of postmenopausal bleeding {{c3::>12 months}} after…
Published	02/10/2024	Normal endometrial thickness post-menopause is {{c1::<4mm}} on Transvaginal ultrasound
Published	02/10/2024	Abnormal endometrial thickness post-menopause is {{c1::>4mm}} or the endometrium is {{c1::irregular}} on Transvaginal ultrasound
Published	02/10/2024	Investigations of Endometrial Cancer are {{c1::Transvaginal ultrasound}}, {{c1::Pipelle biopsy}}, and {{c1::Hysteroscopy with endometrial biopsy}}
Published	02/10/2024	Specialist Management of Endometrial Hyperplasia  {{c1::IUS e.g. Mirena}} {{c1::Continuous oral progestogens e.g. Levonorgestrel}}
Published	02/10/2024	Management of Stage 1 and 2 Endometrial Cancer is{{c1::Total abdominal/laparoscopic hysterectomy with bilateral saplingo-oophorectomy}}
Status	Last Update	Fields